NEW MEDICINES, NOVEL INSIGHTS
Achieving patient-guided drug development
Download the executive summary
Developing effective, patient-focused therapies that deliver meaningful benefits begins early in development and includes patient insights at every step.
Parexel experts offer solutions that keep a sharp and sustained focus on patients.
IN THIS REPORT
SECTION 1
Integrated Development
Four solutions to include the patient perspective in early decision-making.
Go to section
SECTION 2
Advancing PRO Data
What does it take to generate regulatory-grade patient-reported data?
Go to section
SECTION 3
Diversity Strategies
Inclusive strategies for underrepresented patient groups.
Go to section
Contributing Experts
Jakki James
Director, Patient Communications
Jep Poirrier, Ph.D.
Senior Director, Health Economics and Outcomes Research
Katja Rudell
Senior Director, Clinical Outcomes Assessment, Parexel International
Ned Wydysh
Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances
Rachel Smith
Executive Director, Rare Disease, Center of Excellence
Sangeeta Budhia
VP, Pricing & Market Access
Stacy Hurt, MHA, MBA
Chief Patient Officer
Vera Zheng
Senior Vice President, Asia/Pacific Strategy and Head of Greater China, Parexel International
Xoli Belgrave
Senior Director, Head of Clinical Trial Diversity and Inclusion
Contributing Experts
Jakki James
Director, Patient Communications
Jep Poirrier, Ph.D.
Senior Director, Health Economics and Outcomes Research
Katja Rudell
Senior Director, Clinical Outcomes Assessment, Parexel International
Ned Wydysh
Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances
Rachel Smith
Executive Director, Rare Disease, Center of Excellence
Sangeeta Budhia
VP, Pricing & Market Access